About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
Biocon-Media
  > MEDIA
  Overview
  Press Releases
  Media Stories
  Download Center
  Video Gallery
  Photo Gallery
  Media Contacts
  
  
     
 

Press Releases

2017
  2016 2015 2014 2013 2012 2011
2010 2009 2008 2007 2006 2005

 
 
  December 2013
18 Dec  Biocon and Quark Pharmaceuticals
 Collaborate to Develop Novel siRNA based
 Therapeutics
Download Pdf

  November 2013
26 Nov  Biocon & Mylan Receive Indian Regulatory
 Approval for Trastuzumab for Treating
 Breast Cancer
Download Pdf
11 Nov  Biocon Unveils Biocon Academy - A Center
 of Excellence for Advanced Learning in
 Applied Biosciences
Download Pdf

  October 2013
24 Oct  Sustained Momentum in Biopharma &  Research Services delivers 19% growth for
 Biocon
Download Pdf

  September 2013
13 Sep  Biocon Partners with CytoSorbents to
 Market CytoSorb® - A 'First-in-Class'
 Therapy for Sepsis Management
Download Pdf

  August 2013
10 Aug  Biocon Launches ALZUMAb - a
 'First in Class' Novel Biologic Treatment for
 Psoriasis Patients in India
Download Pdf

  July 2013
25 Jul  Biocon Delivers a Healthy Growth of 22%
 driven by strong traction in Biopharma
Download Pdf

  April 2013
25 Apr  Biocon delivers a strong performance of
 18% Revenue Growth in FY13 driven by an
 evolving Product Portfolio & Research
 Services
Download Pdf

  February 2013
24 Feb  Biocon Enhances Partnership with Mylan
 through Strategic Collaboration for
 Insulin Products
Download Pdf

  January 2013
24 Jan  Kiran Mazumdar-Shaw joins U.S.
 Pharmacopeial Convention (USP)
 Board of Trustees
Download Pdf
24 Jan  Biocon's Nine Months Revenue Continues
 to Deliver Steady Growth in FY13
Download Pdf
08 Jan  Biocon Receives Marketing Authorization
 for its Novel Biologic Itolizumab for
 Psoriasis
Download Pdf




   
 
 
 
 
 
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer            © 2016, Biocon. All Rights Reserved